PT  - JOURNAL ARTICLE
AU  - Frentzas, Sophia
AU  - Kao, Steven
AU  - Gao, Rang
AU  - Zheng, Hao
AU  - Rizwan, Ahsan
AU  - Budha, Nageshwar
AU  - de la Hoz Pedroza, Luz
AU  - Tan, Wei
AU  - Meniawy, Tarek
TI  - AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors
AID  - 10.1136/jitc-2022-005829
DP  - 2023 Oct 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e005829
VI  - 11
IP  - 10
4099  - http://jitc.bmj.com/content/11/10/e005829.short
4100  - http://jitc.bmj.com/content/11/10/e005829.full
SO  - J Immunother Cancer2023 Oct 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.